Aurora-A Inhibition Eliminates Myeloid Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-Pd-L1 Therapy in Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-18-3397
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of COX-2 and EGFR by Melafolone Improves Anti-Pd-1 Therapy Through Vascular Normalization and PD-L1 Downregulation in Lung Cancer

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2020English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Vitamin D Enhances the Efficacy of Photodynamic Therapy in a Murine Model of Breast Cancer

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2019English

PD-L1 Mediated the Differentiation of Tumor-Infiltrating CD19+B Lymphocytes and T Cells in Invasive Breast Cancer

OncoImmunology
OncologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy